LDLR and metabolic dysfunction-associated steatohepatitis: Nevertheless, as both NASH patients31 and Npc1−/– tp Ldlr−/− mice (described by Zhang et al. 32) show increased levels of plasma oxidized lipids, our mouse model can be considered a proper model to investigate the contribution of oxidized lipids to the human NASH situation.